The Joint Corp. announced on April 27, 2026 that it had signed an Asset Purchase Agreement effective April 20, 2026 to sell 45 of its corporate‑managed clinics in Southern California to Elite Chiro Group for approximately $2.3 million. Elite Chiro Group will assume operations of 32 clinics immediately through a Management Service Agreement, while the remaining 13 clinics will be transferred once lease assignments are completed.
The sale reduces The Joint’s corporate‑owned clinic portfolio to just three locations out of its 960‑clinic network, completing the company’s plan to become a capital‑light, pure‑play franchisor. The transaction follows two previously announced refranchising agreements that are pending closing, underscoring the company’s aggressive move to shift the bulk of its operations to franchisee ownership.
Financially, The Joint reported revenue of $54.9 million for the full year 2025, up from $52.2 million in 2024, and a consolidated net income of $2.9 million in 2025 versus a net loss of $5.8 million in 2024. The company’s gross profit margin stands at 79.55%, reflecting the high‑margin nature of its franchise model. While the $2.3 million sale price is modest relative to the number of clinics, it aligns with the company’s refranchising strategy and contributes to its goal of reducing operational overhead.
"This transaction is a key component of our next phase of growth under The Joint 2.0 and a defining step in our shift to a capital‑light, pure‑play franchisor model," said Sanjiv Razdan, President and CEO of The Joint Corp. "By transitioning nearly our entire clinic portfolio into the hands of experienced franchise operators like Elite Chiro Group, we are streamlining our model, sharpening our focus on driving overall sales growth through franchisee success, and positioning The Joint to deliver longstanding, profitable growth across the portfolio."
The transaction aligns with an industry trend of franchisors shedding corporate‑owned locations to streamline operations and enhance profitability. By reducing its corporate footprint, The Joint is expected to improve operational leverage, lower overhead costs, and increase its focus on royalty and franchise fee revenue streams. The company has guided for 2026 system‑wide sales between $519 million and $552 million, compared with $532.4 million in 2025, indicating confidence in continued growth under the new business model.
The sale of these clinics is a pivotal step in The Joint 2.0 strategy, positioning the company to accelerate growth and profitability through a leaner, franchise‑centric model that leverages the expertise of experienced operators like Elite Chiro Group.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.